• 01 Apr 20

Futura Medical CEO talks regulatory timeline and commercial potential for breakthrough gel

Futura Medical CEO talks regulatory timeline and commercial potential for breakthrough gel

Futura Medical plc | FUM | 12.2 0 0%

    • 213 views

 

Futura Medical PLC's (LON:FUM)  James Barder caught up with Proactive London's Andrew Scott on the back of their 2019 results.

He says the EU filing for MED3000 is likely by the end of July, with the US Food & Drug Administration submission expected by the end of the third quarter.

MED3000 is Futura's fast-acting gel for erectile dysfunction.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Futura Medical, Scancell, Genflow Biosciences, Ilika, Solvonis Therapeutics - Small Cap Weekly Roundup

Companies: Futura Medical plc

Futura Medical's Ken James updates on EU and US regulatory progress for MED3000

Companies: Futura Medical plc

Futura Medical, Greatland Gold, Deltic Energy, Ilika - Small Cap Snapshot

Companies: Futura Medical plc

Futura Medical - Fireside Chat

Companies: Futura Medical plc

Futura Medical CEO James Barder on Futura’s 2024 strong growth, maiden profit and 2025 plans

Companies: Futura Medical plc

Futura Medical sees 'potentially quicker route to market' for its erectile dysfunction formulation

Companies: Futura Medical plc

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top